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Objective: Inflammation and metabolism are closely interlinked. 
Both undergo significant dysregulation following surgery for con-
genital heart disease, contributing to organ failure and morbid-
ity. In this study, we combined cytokine and metabolic profiling 
to examine the effect of postoperative tight glycemic control 
compared with conventional blood glucose management on 
metabolic and inflammatory outcomes in children undergoing 
congenital heart surgery. The aim was to evaluate changes in key 
metabolites following congenital heart surgery and to examine 
the potential of metabolic profiling for stratifying patients in terms 
of expected clinical outcomes.
Design: Laboratory and clinical study.
Setting: University Hospital and Laboratory.
Patients: Of 28 children undergoing surgery for congenital heart 
disease, 15 underwent tight glycemic control postoperatively and 
13 were treated conventionally.
Interventions: Metabolic profiling of blood plasma was undertaken 
using proton nuclear magnetic resonance spectroscopy. A panel of 
metabolites was measured using a curve-fitting algorithm. Inflam-
matory cytokines were measured by enzyme-linked immunosorbent 
assay. The data were assessed with respect to clinical markers of 
disease severity (Risk Adjusted Congenital heart surgery score-1, 
Pediatric Logistic Organ Dysfunction, inotrope score, duration of 
ventilation and pediatric ICU-free days).
Measurements and Main Results: Changes in metabolic and 
inflammatory profiles were seen over the time course from surgery 
to recovery, compared with the preoperative state. Tight glycemic 
control did not significantly alter the response profile. We identi-
fied eight metabolites (3-d-hydroxybutyrate, acetone, acetoacetate, 
citrate, lactate, creatine, creatinine, and alanine) associated with 
surgical and disease severity. The strength of proinflammatory 
response, particularly interleukin-8 and interleukin-6 concentrations, 
inversely correlated with PICU-free days at 28 days. The interleu-
kin-6/interleukin-10 ratio directly correlated with plasma lactate.
Conclusions: This is the first report on the metabolic response to 
cardiac surgery in children. Using nuclear magnetic resonance to 
monitor the patient journey, we identified metabolites whose con-
centrations and trajectory appeared to be associated with clinical 
outcome. Metabolic profiling could be useful for patient stratifi-
cation and directing investigations of clinical interventions. (Crit 
Care Med 2015; XX:00–00)
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Congenital heart disease is relatively common, affecting between 4 and 14 individuals in every 1,000 live births (1). Around one third of affected children require sur-
gery during early childhood. Interventions to correct or pal-
liate congenital heart disease present their own challenges. 
Young age, abnormal circulatory physiology, altered blood 
flow and hypothermia during cardiopulmonary bypass, and 
the trauma of surgery may cause splanchnic hypoperfusion 
and tissue ischemia-reperfusion. The resulting dysregulation 
of homeostatic pathways regulating inflammation, metabo-
lism, and the endocrine system has important clinical conse-
quences including the severity of organ failure and secondary 
morbidity (2–5).
A better understanding of the interaction between homeo-
static derangement and host organ failure in severe illness could 
improve diagnostic accuracy and patient stratification through 
the use of clinically relevant biomarkers. These are chemical 
entities that can be objectively measured and evaluated as an 
indicator of biological processes. Many biomarker studies have 
focused on genomic and transcriptomic methods, alongside 
protein identification in tissues and body fluids. New develop-
ments in metabolic profiling techniques such as nuclear mag-
netic resonance, spectroscopy, and mass spectrometry have 
opened up the possibility to build a picture of the metabolic 
environment in cells, tissues, or biofluids and identify key met-
abolic biomarkers of disease risk, severity and outcome. This 
approach of assessing metabolites within a biological sample 
has been used as a tool for biomarker identification and evalu-
ation in a range of disease states, including surgical oncology, 
sepsis, obesity, and malnutrition (6–12).
We sought to evaluate the metabolic profiling approach and 
explore the effect of a tight versus conventional glycemic con-
trol regime on the metabolic response to surgery in a group of 
children with congenital heart disease. We used this pilot study 
to test the following hypotheses: 1) tight glycemic control post 
surgery reduces the inflammatory and metabolic dysregula-
tion following surgery; 2) metabolic profiling has a role in aug-
menting stratification of and clinical management of children 
undergoing congenital heart surgery.
METHODS
Patients
The study was approved by the Royal Brompton Hospital 
Research Ethics Committee (REC Ref 10/H0801/8). Children 
undergoing elective surgery for congenital heart disease were 
recruited preoperatively, with informed parental/patient consent.
The children in this study were also enrolled into the 
Control of Hyperglycemia in Pediatric Critical Illness trial, 
with a treatment arm of using insulin to target blood glucose 
to a range of 72 to 126 mg/dL (4.0–7.0 mmol/L), and control 
arm of conventional glycemic control, with a target level below 
216 mg/dL (12.0 mmol/L) (13).
Children were eligible to participate in the study if they were 
between 36 weeks of corrected gestational age and 16 years of 
age, if they had been admitted to a PICU, and if they had an arte-
rial catheter in place and were receiving mechanical ventilation 
and vasoactive drugs, with an anticipated duration of treatment 
of at least 12 hours. Children were excluded if they had diabetes 
mellitus, a confirmed or suspected inborn error of metabolism, 
if withdrawal of treatment was being considered, or if they had 
been in a PICU for more than 5 days.
Patient Biological Samples
Peripheral blood was obtained from intra-vascular lines preop-
eratively (at induction of anesthesia), and at serial timepoints 
postoperatively following admission to the PICU. Specifically, 
samples were taken on admission (0 hr), and then at 6, 24, and 
48 hr post surgery for as long as an indwelling vascular catheter 
was in situ. Blood was collected into endotoxin-free sodium 
heparin (168 IU) Vacutainer tubes (Beckton Dickinson, 
Oxford, United Kingdom). Plasma was extracted by centrifu-
gation of blood at 1,200g for 10 minutes and the supernatant 
was stored at –80°C until analysis.
Cytokine Assays
Cytokine concentrations in plasma samples were determined 
in duplicate using MSD MULTI-SPOT immunoassay kits for 
interleukins (IL) 10, 6, 8 and IL-1 receptor antagonist (IL-1ra) 
(Mesoscale Discovery, Gaithersburg, MD), according to the 
manufacturer’s protocol. Analysis was undertaken using MSD 
Workbench, version 3.0.18, on the Sector Imager 2400 (MSD)
Statistical Analysis of Demographic Variables
Values are shown as median (interquartile range) except where 
indicated.
1H NMR Spectroscopic Analysis
The protocols for sample preparation and NMR acquisition 
are based on published protocols by Dona et al (14). A Bruker 
AVANCE III spectrometer (Bruker Biospin, Billerica, MA) with 
a broadband inverse 600 MHz 5 mm Z gradient probe with 
automatic tuning and matching was used for all the 1H NMR 
spectroscopy experiments. Further details are provided in the 
supplementary methods (Supplemental Digital Content 1, 
http://links.lww.com/CCM/B267).
Data Reduction and Multivariate Analysis
The acquired 1H NMR spectra of plasma samples were zero 
filled to 132 K points, Fourier transformed, phase and baseline 
corrected using Bruker Topspin 3.1 (Bruker Biospin) Using 
both in-house developed scripts (Drs T. Ebbels, O. Cloarec, 
and M. Rantalainen) for MATLAB (version 2012b; The Math-
Works, Inc, Natick, MA) and python 2.7.4 (15–17). Further 
details on the analysis and model fitting (18–23) are provided 
in the supplementary methods (Supplemental Digital Content 1, 
http://links.lww.com/CCM/B267).
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Peak Fitting
For deconvolution and relative metabolite quantification in the 
spectra the R (22) package BATMAN (Bayesian AuTomated 
Metabolite Analyzer for NMR spectra) was used (23). Relative 
concentrations for the metabolites were used to obtain Pearson 
correlation matrices and plot heatmaps in python (15–17) using 
the plotting library matplotlib (24). Fifteen metabolites were rel-
atively quantified in this way: lactate, creatine, creatinine, glucose, 
citrate, formate, 3-hydroxybutyrate, acetone, acetate, acetoac-
etate, alanine, valine, isoleucine, leucine, and threonine. Further 
details are provided in the supplementary methods (Supplemen-
tal Digital Content 1, http://links.lww.com/CCM/B267).
RESULTS
Patients
There were 28 patients with a median age of 6.6 months (4.0–
18.9 mo), and median weight of 6.2 kg (4.0–8.52). The median 
number of PICU-free days at 28 days was 24 (20.25–26). Chil-
dren in this cohort were relatively undernourished, with a 
median weight age z score of –2.03 (–2.94 to –1.49). As a marker 
of organ failure, we used the Pediatric Logistic Organ Dysfunc-
tion (PELOD) score. During the first 24 hours, children enrolled 
in the study had a median PELOD score of 11 (11–20.75). Fur-
ther clinical details on the patient clinical variables are shown 
in Table 1. The natures of the congenital heart lesions of the 
children enrolled in the study are shown in Table 2.
Fifteen children had tight glycemic control postoperatively, 
and the remaining 13 had conventional blood glucose manage-
ment. Median glucose (±interquartile range) for tight and con-
ventional glycemic control groups was 6.1 mmol/L (5.8–6.5) 
and 6.7 mmol/L (6–8.02), respectively (p = 0.046). There was 
no difference in age, weight, weight age Z score, PELOD score, 
Inotrope Score, or duration of ventilation and PICU-free days 
between the two groups (Table 3).
Metabolic Profiles Showed No Difference Between 
Glycemic Control and Conventional Glucose 
Management Groups
1H NMR spectra of plasma profiles showed no difference in 
postoperative samples from children with glycemic control 
intervention compared with the control group. The prediction 
metrics for the PLS-DA model of the global 1H NMR profile 
are R2Y 0.75, Q2Y –0.44, and R2Y 0.46, Q2Y –0.78 for the model 
generated using a subset of 15 relatively quantified metabolites.
The model validation metric Q2Y is obtained through cross-
validation, and is therefore a more robust estimate against 
model overfitting. Because in both cases the obtained Q2Y val-
ues are negative, our data do not support the hypothesis of a 
difference in metabolic profiles caused by a tighter glycemic 
control compared with the conventional regime.
Metabolic Profiles Showed a Temporal Evolution 
That Returned Toward the Presurgical Profile With 
Clinical Recovery
Substantial differences between pre- and postoperative samples 
were found. This is summarized in the principal components 
analysis scores plot including all pre- and postoperative time-
points showing that samples are generally well clustered according 
to the time at which they were taken (Fig. 1). As expected from a 
fairly heterogeneous population, there was a considerable amount 
of patient variability that became particularly visible postop-
eratively. The preoperative samples formed a tight cluster in the 
top left corner of the plot inferring relatively low variation in the 
biochemical composition of plasma, whereas samples obtained 
postoperatively were dispersed across the scores plot indicative of 
TABLE 1. Clinical Characteristics of the 
Patients Enrolled in the Study
Clinical Variable Median (IQR)
Age (mo) 6.605 (4.49 to 15.56)
Weight (kg) 6.25 (4.00 to 8.35)
Weight age z score –2.03 (–2.85 to –1.69)
Risk Adjusted Congenital heart 
Surgery Score -1 (25)
2 (2 to 3)
Pediatric Logistic Organ 
Dysfunction score (26) on 
PICU admission
11 (11 to 20.5)
Maximum inotrope score (27) 7.65 (5 to 11.5)
Highest lactate on blood gas 1.95 (1.4 to 2.75)
Highest base excess on  
blood gas
–5.35 (–8.3 to –4.35)
Highest arteriovenous oxygen 
saturation difference on  
blood gas
33.2 (29.05 to 40.1)
Days free of PICU at 28 d 24 (20.5 to 26)
IQR = interquartile range.
TABLE 2. Congenital Heart Defects of 
Patients Enrolled to the Study
Congenital Heart Defect n % of Total
Tetralogy of fallot 8 28.57
Ventricular septal defect 9 32.14
Hypoplastic left heart 2 7.14
Atrioventricular septal 
defect
1 3.57
Truncus arteriosus 2 7.14
Transposition of the great 
arteries
3 10.71
Mitral valve stenosis 1 3.57
Total anomalous pulmonary 
venous connection
1 3.57
Pulmonary atresia 1 3.57
Total 28
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variation in the individual response to surgery or ultrafiltration. 
In general, there was a time trend post surgery with the samples 
immediately postoperatively (orange circles) migrating in the first 
principal component (PC) with the 6-hour (yellow) and 24-hour 
(green) samples differentiating from the preoperative samples in 
the second PC. By 48 hours postoperatively (purple circles), some 
of the patients were comapping with the preoperative samples, 
indicating a recovered metabolic profile.
Changes in Metabolic Profile Were Related to  
Pre- and Postsurgical Factors
The strength of the metabolic response to surgery was influ-
enced by surgical and/or disease severity. This is demonstrated 
by trajectories for two patients that are highlighted in Figure 1. 
Patient 19 underwent major surgery and had a more prolonged 
postoperative recovery (RACHS-1 score 4, invasive ventilation 
for 241 hr and 7 d free of PICU at 28 d). The pattern of change 
TABLE 3. Comparison of Clinical Variables Between Those Children Undergoing 
Conventional Management and Those With Tight Glycemic Control
Conventional  
Management (n = 13)
Tight Glycemic Control  
(n = 15)
Mean glucose during PICU admissiona 6.7 (6.0 to 8.2) 6.1 (5.8 to 6.5)
Mean dose of insulinb 0 (0 to 0) 0.06 (0.01 to 0.08)
Age (wk) 8.25 (2.54 to 18.0) 6.3 (4.6 to 25.84)
Weight (kg) 6.5 (4.4 to 9.15) 6 (3.9 to 7.5)
WAZ –1.96 (–2.61 to –1.7) –2.13 (–3.34 to –0.82)
RACHS score 2 (2 to 3.5) 2 (2 to 3)
PELOD score 11 (11 to 16) 11 (11 to 21)
Duration of ventilation (hr) 48 (35.5 to 108) 72 (48 to 168)
PICU-free days at 28 d 24 (23 to 26) 21 (20 to 26)
ap = 0.046.
bp = 0.002.
Figure 1. Principal component analysis score plots for the full nuclear magnetic resonance profile (A) and cytokine measurements (B). Coordinates 
are colored according to time of sampling and show systematic changes in both metabolite and cytokine profiles over time. Timepoint 1 (red): preop; 
timepoint 2 (orange): 0 hr postop; timepoint 3 (yellow): 6 hr postop; timepoint 4 (green): 24 hr postop; timepoint 5 (purple): 48 hr postop. We draw 
attention to this for two patients with different clinical severities by connecting the coordinates of their plasma profile in chronological order. The patient 
with mild disease (blue line) has a smaller trajectory than the patient with severe disease (red), who had a more deranged trajectory that did not recover 
to baseline by the end of the sampling period (48 hr post surgery).
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in metabolic profile over time demonstrates that this patient 
had a correspondingly strong metabolic response. In contrast, 
a tighter trajectory was seen in samples from patient 26 whose 
surgery was less severe and recovery quicker (RACHS-1 score 
2, invasive ventilation 21 hr and 25 d free of PICU at 28 d).
Comparison of the preoperative samples with samples collected 
immediately postoperatively showed clear differentiation in the 
first PC (PC1), with coclustering of preoperative samples (Fig. 2A).
We analyzed the loading plots for the PCA model (Fig. 3, 
A and B) to identify metabolites that had significantly higher 
concentrations in the postoperative samples. Those identi-
fied included acetate, acetoacetate, acetone, alanine, citrate, 
formate, glucose, 3-hydroxybutyrate, isoleucine, leucine, 
N-acetylated glycoprotein, threonine, and valine.
Analysis of Key Metabolites in Predictive Models of 
Clinical Outcome
The loadings plot highlighted the influence of therapeutically 
administered drug and nutrition resonances (Fig. 3, B). This 
made it crucial to develop a sound analytical approach to iden-
tify relevant compounds that might be hidden by the peaks of 
some of these agents.
We recorded all the administered drugs and feeds and 
undertook analysis of their metabolic profiles. We then incor-
porated these data into our patient sample analysis. We then 
examined those integrals from fitted peaks that showed a rela-
tionship with clinical factors, but which were independent of 
the influence of any exogenous agents.
We selected the most significant metabolites identified in the 
multivariate analyses, then deconvolved and relatively quanti-
fied them. In addition to the metabolites identified through 
this method, we included known markers of organ dysfunc-
tion in critical illness. These included lactate (a well-established 
marker of tissue perfusion), creatine and creatinine (markers 
of muscle metabolism and renal function, respectively).
PCA scores plots based solely on the quantified metabolites gave 
similar results to those models using the global spectral profile (Fig. 2, 
B). However, samples collected preoperatively were not so tightly 
clustered and one individual, denoted by an asterisk, appeared as an 
outlier postoperatively. The profile from this individual was distin-
guished from the rest mainly by high levels of lactate.
To more specifically identify the spectral features associated 
with the observed time course, OPLS regression was performed 
against time. Analysis of the regression coefficients revealed that 
the predominant variables largely match the highest loadings of 
PC1 on the pre- versus postoperative whole profile PCA plot.
Next, we used orthogonal partial least squares discriminant 
(OPLS) analysis and OPLS-DA to screen for patterns in the full 
plasma profiles across individual timepoints.
Using the 15 fitted metabolites, the OPLS models on samples 
taken immediately postoperation indicated moderate predic-
tive capacity of the fitted metabolites for clinical outcome. These 
included RACHS-1 score (R2Y = 0.70, Q2Y = 0.26), PELOD 
(R2Y = 0.66, Q2Y = 0.17), and PICU-free days (R2Y = 0.71, Q2Y = 0.11).
By 6 hours post operation, the ability of the metabolite panel 
to predict clinical outcome was stronger: RACHS (R2Y = 0.77, 
Q2Y = 0.70), PELOD (R2Y = 0.73, Q2Y = 0.70), and PICU-free 
days (R2Y = 0.70, Q2Y = 0.69). In addition, some predictive 
capacity of the metabolite panels for inotrope score (R2Y = 0.64, 
Q2Y = 0.59) and mechanical ventilation hours (R2Y = 0.68, 
Q2Y = 0.37) was evident.
Cytokine Profiles Had a Similar Postoperative  
Time Trajectory
PCA scores plots of the cytokine measurements (Figs. 1, B and 
2, C) displayed a similar scattering pattern to the corresponding 
Figure 2. Principal component analysis score plots for preoperative (cyan) and postoperative (red) detailing the variability in the full nuclear magnetic 
resonance profile (A), cytokine concentrations (B), and quantified metabolites (C).
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Figure 3. Loadings for the first principal component, projected onto the median nuclear magnetic resonance spectra for both pre- and postsurgery 
samples: δ 4.3–0.6 region (A) and δ 8.1–5.1 region (B).
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metabolite scores plots, with preoperative samples clustering 
tightly and the samples from subsequent timepoints demon-
strating a trajectory through time. However, in contrast to the 
metabolic profiles, cytokine levels regressed to preoperative 
values as early as 6 hours postoperatively for some patients. The 
key cytokines influencing the deviation in PC1 (corresponding 
to the immediate response to surgery) were an increase in the 
IL-6/IL-10 ratio and IL-1ra concentrations, which increased 
rapidly post surgery and then smoothly decayed back to 
the baseline. The other cytokines followed a similar but less 
defined pattern.
At 6 hours post surgery, concentrations of some cytokines 
displayed inverse significant correlations with the subsequent 
number of days free of PICU at 28 days (IL-1ra – r: –0.62, 
p = 0.017; IL-6 – r: –0.56, p = 0.034; IL-8 – r: –0.64, p = 0.013; 
IL-10 – r: –0.71, p = 0.0041). For IL-6 and IL-8, concentra-
tions measured at 24 hours continued to have association with 
PICU-free days at 28 days (IL-6 – r: –0.73, p = 0.026; IL-8 – 
r: –0.76, p = 0.017).
As with the metabolic profile data, no significant difference 
was noted in cytokine concentrations between the postopera-
tive glycemic control groups.
Assessment of the Integrated Response of 
Metabolites and Cytokines to Congenital Heart 
Surgery
To examine relationships of the key metabolic and inflam-
matory markers, we prepared a correlation map, which 
showed associations between coherent groups of variables. We 
observed a significant association between IL-6 and IL-8, the 
ketone bodies (acetone, acetoacetate and 3-d-hydroxybutyr-
ate), and the branched chain amino acids (valine, leucine, and 
isoleucine) across all time points (Fig. 4, A–C).
Some relationships varied across time. For example, pre-
operatively, alanine was inversely correlated with ketone body 
levels. Lactate and creatine were strongly correlated with IL-6, 
IL-8, and the IL-6/IL-10 ratio (Fig. 4, A).
Postoperatively, we observed a change in association pat-
tern. Immediately postoperatively 3-d-hydroxybutyrate, aceto-
acetate, and to some extent acetone were positively correlated 
with the branch chain amino acids, particularly leucine (Fig. 4, 
B). Another significant correlation immediately postopera-
tively was an inverse association between the ketone bodies 
and cytokines IL-6 and IL-8. Neither of these correlations per-
sisted through to later timepoints (Fig. 4, C).
Other correlations of interest included citrate and ace-
tate, evident only in samples obtained immediately post 
operation, and between alanine and the branched chain 
amino acids, which showed a strong positive correlation 
postoperatively.
We also investigated the correlation of the quantified lac-
tate with the IL-6/IL-10 ratio and found a strong correlation 
on preoperative samples (r = 0.98; p = 3.15–5). This correla-
tion becomes nonsignificant immediately post operation 
(r = –0.38; p = 0.169), but reverts to the preoperative status 
afterward (r = 0.76; p = 1.75–6).
DISCUSSION
Metabonomic technology has been applied to several studies 
in critical care and neonatal medicine (28). However, previ-
ous studies have largely ignored confounders such as drugs 
(in this case, particularly antibiotics, sedatives, and anesthet-
ics) and feed type. The spectral signatures from critically ill 
patients are known to be heavily “contaminated” by signals 
from exogenous resonances from treatments such as drugs, 
intravenous feeds, and organ perfusion solutions (29). The 
raw data from plasma spectra were confounded by metab-
olites derived from administered feeds and drugs and dis-
played very complex and dynamic biological composition. 
We were concerned that this would obfuscate large regions of 
the spectra. Therefore, we developed a method of peak fitting 
and relative signal quantification in plasma spectra, which 
was shown to be robust by demonstrating association with 
known metabolic biomarkers of outcome (such as lactate) 
and some of the important clinical outcomes, despite being a 
small patient cohort.
No Effect of Glycemic Control Was Found on Clinical 
Outcome or on Metabolite or Cytokine Responses to 
Surgery
Our patient cohort was a subset of patients recruited to a larger 
clinical trial of glycemic control in 1,300 critically ill children 
(13). We examined the effect of tight glycemic control on the 
global metabolic profile and a cytokine panel in response to 
congenital heart surgery when compared with the standard 
glycemic control procedures. While glucose concentrations 
differed between groups, the magnitude was small, but sta-
tistically significant (0.6 mmol/L or 10 mg/dL). In the wider 
clinical trial, a similar small but significant difference in mean 
blood glucose concentrations between the two groups of 0.42 
mmol/L or 7.6 mg/dL was reported (13).
We did not observe any difference in inflammatory or 
metabolic parameters, or in clinical outcome. It was not pos-
sible to obtain any reliable OPLS-DA model discriminating 
between the two glycemic control regimes at any of the time-
points after insulin administration started, using full plasma 
metabolic profile, relatively quantified metabolites, or cytokine 
measurements.
Our data are consistent with results from the wider 
clinical trial, which concluded that tight glycemic control 
in critically ill children had no significant effect on major 
clinical outcomes (13).
Metabolic Panels Reflect the Effects of Surgery and 
Clinical Outcome
Our analytical approach enabled us to uncover profound 
changes in plasma composition following heart surgery in crit-
ically ill infants and children. Each patient’s metabolic response 
took a trajectory that demonstrated distinct phases relating to 
the pre-/postoperative stage. Each individual demonstrated a 
unique response to the surgery and this could be mapped as a 
patient journey, whereby both the metabolic and the cytokine 
panels could be followed and modeled temporally.
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We noted, even in this small patient cohort, that severity of 
surgery and critical illness affected the nature of the postopera-
tive metabolic trajectory and its return to baseline. It would 
be interesting to explore this in a larger cohort and uncover 
important preoperative and postoperative factors including 
cyanosis, heart failure, splanchnic ischemia, and the effects of 
any intra- or postoperative complications.
Our population was undernourished, as measured by the 
weight age z score. Children with congenital heart disease are 
known to exhibit early and progressive falls in their growth 
trajectory compared with healthy children, with reductions 
in WAZ score, head circumference, and length for age z score 
(30, 31). It is also known that surgery and bypass, and the bur-
den of cardiac failure and chronic disease, result in significant 
metabolic and nutritional stress. Furthermore, inadequate 
nutritional intake in the postoperative period results in fur-
ther challenges to restoring normal growth parameters (32, 
33). Our patient cohort received standard nutritional care 
pre- and postoperatively. No additional dietetic interventions 
are currently in place in our institution. Our analysis has dem-
onstrated that changes in feed have a rapid and strong effect 
on metabolic profile, and it would be interesting to compare 
the profile with that in well-nourished children. The reduction 
in plasma very low-density lipoprotein concentrations postop-
eratively and increase in ketone bodies is consistent with fast-
ing of these children. Thus, despite the confounding variables, 
it was possible to observe some interesting relationships that 
warrant further investigation.
Lactate (34–36), inflammatory cytokines, and IL-6/IL-10 
ratio (5, 37) have been shown to be markers of outcome sever-
ity in critically ill patients. The former has been shown to cor-
relate well with classical scoring systems of critical care, such 
as Acute Physiology and Chronic Health Evaluation II (37, 
38) Our data demonstrate an association between inflamma-
tory cytokine balance (IL-6/IL-10 ratio) and lactate, suggest-
ing a close relationship between inflammation and metabolic 
derangement in the days after surgery for congenital heart 
disease. The increase in N-acetylated glycoprotein fragments 
immediately post-surgery is consistent with inflammation, 
which also reflects the general spike in plasma cytokines.
Using the relatively quantified metabolites, it was possible 
to obtain reliable OPLS models for the PELOD and RACHS-1 
clinical scores, particularly in the samples taken in the early 
postoperative period (on PICU admission and at 6 hr post 
surgery). Analysis of the OPLS model coefficients showed 
that both the RACHS-1 and the PELOD scores were mainly 
associated with lactate, citrate, and to a lesser extent creatinine 
and alanine. Ketone bodies, particularly acetoacetate and cre-
atine, displayed the inverse association with these scores. In all 
analyses, creatine showed the inverse trend of creatinine (more 
creatinine and less creatine associated with higher scores and 
greater severity). All these metabolic parameters were also 
associated with PICU-free days but with their trends reversed, 
as expected. The main metabolites positively associated with 
inotropic score were alanine, citrate, and lactate, with creatine 
inversely correlated. In general, ketone bodies seem to correlate 
with better surgical outcomes, whereas citrate, lactate, alanine, 
and higher creatinine-to-creatine ratio with the inverse.
Our data are similar to previously published work regard-
ing metabolism in adults with critical illness (39). Increased 
catecholamine, cortisol, and glucagon secretion in critical ill-
ness are known to promote lipolysis and ketone body genera-
tion (39, 40). Triglycerides are metabolized to fatty acids and 
glycerol, a gluconeogenic substrate. High glucagon and low 
insulin concentrations also promote oxidation of free fatty 
acids to acyl CoA. The latter is hepatically converted to ketone 
bodies (β-hydroxybutyrate, acetoacetate, and acetone), as a 
water-soluble fuel source.
To our knowledge, this work is the first metabonomic 
study in children undergoing surgery for congenital heart 
disease. The study demonstrates that nuclear magnetic reso-
nance can be applied to biological samples from children with 
congenital heart disease, and that changes occur in metabolic 
profile during the response to the surgical insult. Because the 
Figure 4. Pearson correlation heat maps for the presurgery (A), immediately postsurgery (B), and combined 6–48 hr postsurgery samples (C). Cells with 
opaque coloring specify correlations with a value of p < 0.05 (Student t test). Red cells indicate positive correlation and blue cells negative correlation.
Copyright © 2015 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.
Clinical Investigation
Critical Care Medicine www.ccmjournal.org 9
postoperative metabolic spectra are heavily confounded by 
resonances deriving from feeds and drugs, the use of the whole 
1H NMR plasma or urine profile can be quite limited, other 
than to identify gross outliers. Despite these shortcomings, we 
show that through an improvement in the prep-processing 
procedures, it is possible to reliably measure the evolution of 
various markers of interest.
We accept that our study group was small, and for this rea-
son we could not keep separate training and test datasets for a 
more stringent assessment of the multivariate models. To fur-
ther validate the PLS models in the setting of a small sample 
size, a permutation test was performed on the most relevant 
clinical parameters (such as surgical and disease severity scores 
and outcomes). In this test, the models are refitted and cross-
validated multiple times, after permuting class labels or depen-
dent variable values. The p values for the tests to assess the 
metabolite panel were highly significant (< 0.01) for RACHS 
score, PELOD score, and PICU-free days in models using data 
from samples at 6 hours post operation. Nevertheless, any puta-
tive marker identified in this study has to be properly validated 
in a larger cohort, as it is likely that the full extent of variability 
in this type of critical care population has been under sampled.
Because ketone bodies and lipid metabolism were indicated 
as predictive of clinical outcomes and displayed alterations in 
response to surgical insult, additional studies should include 
evaluation of liquid chromatography-mass spectrometry to 
profile the lipidomic response to critical illness. Liquid chro-
matography-mass spectrometry methods generate 2D datasets 
(chromatographic retention time and mass-to-charge ratio) 
and have less form overlap between exogenous and endoge-
nous molecules. Our data on inflammatory links to metabolic 
shifts and clinical outcome post surgery suggest that targeted 
mass spectrometry methods could be of interest to identify 
other biological markers of acute inflammation.
In summary, our study suggests that metabolic profil-
ing could be a clinically relevant tool for stratifying patient 
responses to congenital heart surgery. Furthermore, we show 
evidence that tight glycemic control does not impact the post-
surgical metabolic profiles, supporting the clinical trial from 
which this study was drawn that failed to show improvement 
in early clinical outcomes with tight glycemic control. With 
improved data analysis workflows and targeted metabolite 
quantification, detailed and informative metabolic data could 
inform patient stratification and critical care management.
In summary, we have identified a panel of metabolites, 
which is predictive of clinical outcome. This metabolite panel 
will require validation in a larger cohort of children.
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